MEDSIR, a leading international company in oncology research, has announced the results of the PHERGuide study during the 2025 San Antonio Breast Cancer Symposium (SABCS). This research, presented as ...
Researchers identified a new, sticky form of mitochondrial DNA damage that builds up at dramatically higher levels than in ...
ASH 2025 research shows cancer can arise not just from mutations but from broken DNA architecture. AI reveals how lost genome loops silence tumor suppressor genes.
An international research team has identified a human protein, ANKLE1, as the first DNA-cutting enzyme (nuclease) in mammals ...
Cancer isn't just about broken genes—it's about broken architecture. Imagine a city where roads suddenly vanish, cutting off ...
Mitochondria are often described as the cell’s power plants, but a wave of new research suggests their genetic material may ...
New research has identified key factors that drive lung tumor evolution and influence outcomes, describing a previously ...
Using lung cancer biospecimens from the Sherlock-Lung study, an international team led by National Institutes of Health (NIH) ...
In an interview with Targeted Oncology ®, Stefania Morganti, MD, PhD, research fellow at the Dana-Farber Cancer Institute, ...
Foresight’s technology will be integrated into Natera’s Signatera platform and is expected to be launched for clinical use in ...
European fertility clinics used cancer-causing sperm for 17 years, prompting urgent calls for genetic screening reforms and ...